Inventor · disambiguated record
Reza Mazhari
Also filed as: MAZHARI REZA
8 granted patents·7 pending applications·7 citations·filing 2005–2022
79Inventor score
Files withREXAHN PHARMACEUTICALS INC6CERECOR INC4ARTESIAN THERAPEUTICS INC2CARDIOXYL PHARMACEUTICALS INC2AVALO THERAPEUTICS INC1
Top patents by PatentIndex Score
15 records- 0188US10202363B2Compounds, compositions and methodsCERECOR INC·Filed 2015·Granted Feb 12, 2019·5 cites·25 claims
- 0287US11479542B2Compounds, compositions and methodsCERECOR INC·Filed 2020·Granted Oct 25, 2022·2 cites·12 claims
- 0373US12410153B2Compounds, compositions and methodsAVALO THERAPEUTICS INC·Filed 2022·Granted Sep 9, 2025·0 cites·21 claims
- 0462US10710976B2Compounds, compositions and methodsCERECOR INC·Filed 2019·Granted Jul 14, 2020·0 cites·17 claims
- 0559US2020231553A1Quinoxalinyl-piperazinamide methods of useREXAHN PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0656US10570101B2Quinoxalinyl-piperazinamide methods of useREXAHN PHARMACEUTICALS INC·Filed 2018·Granted Feb 25, 2020·0 cites·12 claims
- 0752US10278971B2Fluorocyclopentenylcytosine methods of useREXAHN PHARMACEUTICALS INC·Filed 2017·Granted May 7, 2019·0 cites·17 claims
- 0851US9969698B2Quinoxalinyl-piperazinamide methods of useREXAHN PHARMACEUTICALS INC·Filed 2016·Granted May 15, 2018·0 cites·13 claims
- 0951US2019275042A1Fluorocyclopentenylcytosine methods of useREXAHN PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1050US9782410B2Fluorocyclopentenylcytosine methods of useREXAHN PHARMACEUTICALS INC·Filed 2016·Granted Oct 10, 2017·0 cites·21 claims
- 1144US2011160200A1Nitroxyl Progenitors for the Treatment of Pulmonary HypertensionCARDIOXYL PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 1240US2016081951A1Nitroxyl donors for the treatment of pulmonary hypertensionCARDIOXYL PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1339US2013274342A1Compositions and methods for treating coughCERECOR INC·Filed 2013·Application pending·0 cites
- 1430US2008090827A1Compounds With Mixed Pde-Inhibitory and Beta-Adrenergic Antagonist or Partial Agonist Activity For Treatment of Heart FailureARTESIAN THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 1529US2008255134A1Cardiotonic Compounds With Inhibitory Activity Against Beta-Adrenergic Receptors And PhosphodiesteraseARTESIAN THERAPEUTICS INC·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →